Antigenic Drift in Visna: Virus Variation During Long-term Infection of Icelandic Sheep
|
|
- Barrie Hampton
- 5 years ago
- Views:
Transcription
1 J. gen. Virol. (1983), 64, Printed in Great Britain 1433 Key words: visna virus~antigenic drift/persistent infection/retroviruses Antigenic Drift in Visna: Virus Variation During Long-term Infection of Icelandic Sheep By ROGER LUTLEY, GUDMUNDUR PI~TURSSON, PALL A. PALSSON, GUDMUNDUR GEORGSSON, JOHN KLEIN I AND NEAL NATHANSON 1. Institute for Experimental Pathology, University of lceland, Reykjavik, Iceland and 1Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, U.S.A. (Accepted 24 February 1983) SUMMARY A group of 20 Icelandic sheep were infected intracerebrally with visna virus strain 1514, and 209 virus isolates were obtained from the blood, cerebrospinal fluid, and central nervous system (CNS) over a period of 7 years, during which eight animals developed clinical signs of visna necessitating sacrifice. (i) Using type-specific antisera, it was found that 12 (16%) of 76 isolates tested escaped neutralization. These 12 variant viruses were distributed randomly among animals and over time, and did not replace the infecting strain even though all sheep developed homotypic antibody within 3 months of infection. The one exception was sheep no (an animal without clinical visna), where the last six isolates were variants. (ii) A total of 35 blood and CNS isolates from seven of these sheep (including five with clinical visna) were tested against serial samples of their own sera. Autologous antisera neutralized all isolates tested with the exception of isolates from sheep None of the isolates obtained at sacrifice from the five sheep with clinical visna escaped neutralization with autologous antisera. These data suggest that although variant viruses are encountered at considerable frequency during long-term infection of Icelandic sheep, the variants usually do not replace the infecting strain. Antigenic drift does not appear to be essential for virus persistence or for the development of clinically evident CNS lesions. INTRODUCTION Visna is a chronic central nervous system (CNS) infection of sheep with a naturally occurring ovine retrovirus (Haase, 1975 ; P&ursson et al., 1976,!978, 1979). The virus persists indefinitely after infection, although at low levels, and the infected sheep develop subacute encephalitis which may progress to clinical paralysis at irregular intervals from a few months to many years after inoculation. Infected Icelandic sheep regularly develop neutralizing antibodies in their serum within 3 months of infection and often have high titres of neutralizing antibody in the cerebrospinal fluid (CSF) as well (Nathanson et al., 1979). Gudnad6ttir (1974) originally reported a single instance in which a virus isolate from an infected sheep could escape neutralization by the animal's own (autologous) serum. Narayan et al. (1977a, b, 1978) have conducted detailed studies on Hampshire and Border-Leicester sheep which confirmed and extended this observation. Antigenic variation is a potentially important observation because it could play a role in virus persistence and could provide a mechanism for the unpredictable appearance of focal CNS lesions. To determine the quantitative importance of antigenic drift, we have examined over 70 virus isolates obtained over 7 years from the blood (buffy coat), CSF or CNS of 20 Icelandic sheep infected with the 1514 strain of visna virus. Since Icelandic sheep develop neurological signs, which are rarely seen in most other breeds of sheep following visna infection, it was possible to /83/ $ SGM
2 1434 R. LUTLEY AND OTHERS relate antigenic variants to clinical disease. Our observations indicate that variant viruses occur at considerable frequency but do not appear essential to virus persistence or disease occurrence. METHODS Experimental animals and virus isolates. A group of 20 Icelandic sheep were inoculated intracerebrally with 106 TCDs0 of strain 1514 of visna virus, as described previously (P6tursson et al., 1976). Each sheep in this group was tested repeatedly for buffy coat virus in an explant-cocultivation system (P6tursson et al., 1976), and serial serum samples were also collected. These 20 sheep were studied for over 7 years, and animals developing severe illness were sacrificed and a diagnosis was made from clinical signs and a complete autopsy. At sacrifice, a standard set of CNS and other tissues was tested for virus by explantation and cocultivation (P6tursson et at., 1976). Table 1 summarizes the clinical course and virus isolations made from these animals. In addition, a group of five sheep were injected intracerebrally with 106 TCD~o of the 796 strain of visna virus, and 13 buffy coat isolates obtained from these sheep were included as a control on the typing procedure described below. Neutralization tests. Neutralization tests followed our published procedure (P6tursson et al., 1976). Each isolate was passed once in sheep choroid plexus (SCP) cultures, titrated and frozen at - 70 C. Tests were conducted by mixing an expected 10 ~ TCDso in 100 ~tl of diluent with 100 ~tl of serum dilution; mixtures were held at 4 C for 48 h and then inoculated into four SCP cultures (200 ~tl per culture) which were observed for 2 weeks. Simultaneous titration indicated that, in almost all tests, virus titres were between 1015 and TCDso. Replicate testing of selected sera or isolates indicated that typings were reproducible and serum titres repeatable within a twofold range. Typing with referenceant&era. All tests included two prototype viruses, strains 1514 and 796. Strain 1514 was the infecting virus and strain 796 was included because it is known to be serologically distinct. Although distinguish- Table 1. Clinical course, virus isolates, and antibody response in Icelandic intracerebrally with 106 TCDso of visna virus strain 1514 and followed for Neutralizing Virus isolates antibodyt Years to Diagnosis at, x ~ f. Sheep sacrifice sacrifice* Blood CSF CNS Serum CSF < Other < Visna Other Visna Visna (P):~ Other Visna ND ND "5 Visna 6 0 0(P) Visna 4 1 0(P) Other Other < Visna < Visna < Other 9 4 0(P) Other Totals sheep injected 7.5 years * Blank space indicates animal alive. Other diagnoses: 1519, traumatic tap; 1522, possible enterotoxaemia, 1525, paralysis of unknown cause; 1550, paratuberculosis; 1551, severe arthritis; 1556, traumatic tap; 1557, splenomegaly and debilitation. Blood isolates over 7-5 years; CSF isolates at 1 to 5, and 79 months. Neutralizing antibody titres to 1514 virus were measured and are shown as median of three to ten determinations at l to 4 years after infection. ~/P, Perfused. ND, Not determined.
3 Antigenic drift of visna virus 1435 Table 2. Typing of blood isolates from sheep infected with visna virus strains 1514 or 796." representative data using homotypic antisera Time of Typing antisera* In~cting isolate x, Antigenic virus Sheep (months) Divalent type Reference 128 < virus 1514 Reference < virus <4 > < <4 > < <4 <4 32 Neither 30 8 < < < <4 <4 32 Neither < < < <4 > < <4 <4 128 Neither <4 > < <4 > < < <4 > < <4 >250 > < * Typing antiserum: titre of typing antiserum against each virus isolate. able, the two strains were related, since 1514 was derived from 796 by multiple animal and SCP passages, as summarized by Narayan et al (1981). Using these two viruses, three typing sera were selected: serum 1514 (from a sheep infected with strain 1514) would neutralize 1514 but not 796; serum 796 (from a sheep infected with strain 796) would neutralize 796 but not 1514; divalent sera (from a sheep with a long-term infection with 1514 virus) would neutralize both viruses. An isolate was classified, according to its neutralization by the three reference sera, as 1514-like, 796-1ike, or like neither (Table 2). Tests with autologous sera. From the 20 sheep, a subgroup of seven animals was selected for autologous testing, with emphasis on animals yielding many isolates or animals developing clinical visna. From each such animal, serial sera, collected throughout a period of observation, were tested against the infecting strain 1514 and against a panel of autologous isolates from blood and CNS (where available). Neutralization tests followed the protocol described above. RESULTS A group of 20 Icelandic sheep were injected intracerebrally with 106 TCDso of visna virus, strain 1514, and followed for 7-5 years, with serial collection of blood and CSF for virus isolation and of serum for antibody determination. All sheep became infected as judged by virus isolation and serum antibody responses (Table 1). During the first 7 years of study, 149 blood isolates were made from 18 of the 20 animals (Table 1). From these 149 isolates, 59 were selected to represent 17 of 18 virus-positive sheep and the first 6 years of study; these 59 isolates were typed with reference antisera. In addition, blood
4 1436 R. LUTLEY AND OTHERS 151sl i I, 15191_.~ 1520~_..~ 1521~,.~) 1522~..~ 1523~.~,~.., ~N,~b,'N~l I d 1525 = [] [] 1557 t 0.5 [] [] r-i [33:3 I I I [] m (3(3 08) k~ R~ Time after infection (years) [] Fig. 1. Typing of 76 isolates from blood, CSF or CNS of 20 Icelandic sheep inoculated intracerebrally with 106 TCDs0 of visna virus strain 1514 and followed for 7 years. Typing was by neutralization with sera specific for 1514 and for 796 viruses. Squares indicate blood isolates, the circles CNS/CSF isolates; open symbols represent 1514-like serotype (64), the shaded symbols variant viruses (12) not neutralized by antiserum to 1514 virus. isolates from six sheep were tested with autologous sera, using one to seven isolates per animal (total of 24 isolates). As sheep developed severe illness, they were sacrificed and virus was isolated from CNS and other tissues. As summarized in Table 1, during the first 7-5 years of observation, 15 of 20 sheep were sacrificed, eight with clinical visna and seven with other diagnoses. CNS isolates were available from five animals with clinical visna and three with other diagnoses. A total of 17 CNS isolates were tested with reference antisera; 11 of these were also tested in the autologous system. Blood isolates Typing with reference antisera Table 2 shows representative results with prototype virus strains and with isolates from sheep infected with each of the prototype viruses. Several points are apparent. The reference typing sera clearly distinguished each prototype virus and did not cross-neutralize the heterotypic virus. Most isolates from 1514 virus-infected sheep were readily typed as 1514-like and isolates from 796 virus-infected sheep as 796-1ike. Finally, some isolates are classified as 'like neither' since they were not neutralized by either homotypic or heterotypic sera although they were neutralized by the divalent serum. Fig. 1 sets forth typing results on 20 sheep infected with strain 1514, for 59 blood isolates. About 15~ of isolates (9 of 59) are clearly different. All of the variant isolates exhibited a consistent pattern in that they were not neutralized by either homotypic serum but were neutralized by the divalent serum (see Table 2). It is apparent that the frequency of variants did not increase with time after infection. Also, variants are distributed widely among individual sheep, and when variants occurred they did not replace the parental virus. The one exception is sheep 1557, where the last three blood isolates were variants. CNS isolates Fig. 1 also presents data on i7 isolates from the CSF or CNS of 10 animals from the same
5 Antigenic drift of visna virus 1437 Table 3. Autologous neutralization tests on blood and CNS isolates from Icelandic sheep infected with visna virus strain 1514: sheep 1520, sacrificed at 2.5 years with clinical visna Isolate t" Source Years Blood CNS / Reference strain Sera, years after infection * > >500 >500 - > * Titre < 4. Table 4. Autologous neutralization tests on blood and CNS isolates from Icelandic sheep infected with visna virus strain 1514: sheep 1553, sacrificed at 7.2 years with clinical visna g Source Isolate Years Blood 0-3 CNS Reference strain at" Sera, years after infection * >250 > *, Titre <4. group of 20 infected sheep, including five animals with a clinical diagnosis of visna. Of these 17, three isolates were variants, and these came from sheep Of the total of 76 isolates typed by reference antisera, 12 (16~) were variants. However, antigenic drift (consistent isolation of variant viruses) was seen only for sheep Blood and CNS isolates Neutralization by autologous antisera To determine whether an infected sheep can neutralize the virus replicating in its own tissues, blood and/or CNS isolates were examined from seven sheep, of which five had clinical signs of visna. In each instance serial sera collected at intervals, between infection and death, were tested for neutralization titre against one to eight isolates from the same animal, and against 1514 and 796 viruses. Data for three representative sheep are shown in Tables, 3, 4 and 5. Tables 3 and 4 illustrate two animals (1520 and 1553) which failed to show antigenic variation. Serial sera neutralized all blood and CNS isolates just as well as the infecting strain Yet the potential of these sera to distinguish some variants is indicated by the failure of the serum from 1520 to neutralize reference strain 796. Table 5 shows that antigenic drift was clearly evident for sheep The firsf two blood isolates were neutralized but all of the subsequent six isolates from blood or CNS escaped neutralization. Autologous tests are summarized in Fig. 2 for seven animals and 35 isolates. Drift was seen only for sheep 1557, described above.
6 1438 R. LUTLEY AND OTHERS 1518 ~_].._] ' U ~ ) ' ' ' 1520[._1 d ,---~ e I [ [ I lss2l_l_j I I ] t I [--] ~ ~ Time after infection (years) k3 6 7 Fig. 2. Autologous neutralization tests on 35 isolates from blood, CSF or CNS of seven Icelandic sheep inoculated intracerebrally with 106 TCDso of visna virus strain 1514 and followed for 7 years. In autologous neutralization each isolate was tested against serial serum samples from the same sheep. Squares indicate blood isolates, the circles CSF/CNS isolates; open symbols represent isolates neutralized by autologous sera (29), the shaded symbols isolates not neutralized by autologous sera (6). Table 5. Autologous neutralization tests on blood and CNS isolates from Icelandic sheep infected with visna virus strain 1514: sheep 1557, sacrificed at 6"6 years with clinical visna Isolate Sera, years after infection g "~ "3 Source Years l Blood 0.5 * > >32 > CNS Reference strain * Titre <4. DISCUSSION The use of sera readily capable of distinguishing the two antigenic variants (1514 and 796) provides evidence of the specificity of the typing system. The system is further authenticated by the observation that most sheep yielded isolates consistent with the infecting serotype. The fact that all variant viruses consistently escaped neutralization by both homotypic reference sera but were neutralized by the divalent serum (obtained from a long-term infected sheep) suggests that the divalent serum recognized additional antigenic determinant(s) which are shared by prototype and variant viruses. The methods used in this study are relatively insensitive, since the homotypic typing sera are polyclonal and may fail to identify minimal antigenic variants. The use of monoclonal antibodies might reveal a higher frequency of variants, since monoclones can distinguish single amino acid changes in neutralizing glycoproteins (Laver et al., 1979a, b). Because the 1514 strain was not plaque-purified, it could well have included a minority population of antigenic variants. Furthermore, studies of influenza and rabies viruses with monoclonal antibodies (Gerhard et al., 1980; Wiktor & Koprowski, 1980) show that even cloned viruses always contain a minority population (of the order of 10 -s to 10-6) of each specific antigenic variant. The data of Clements et al. (1980) and of Scott et al. (1979) indicate that antigenic variants of visna virus differ from their respective parents by one or more point
7 Antigenic drift of visna virus 1439 mutations. Thus, it is likely that variants are constantly being generated and are present in all stocks of visna virus. These considerations suggest that long-term animal infection provides a system for the selection of variant viruses rather than for their production. The finding that 16~ of isolates register as variants using a relatively insensitive typing system indicates an increase in their frequency during infection, since the parent 1514 stock contained much less than 1 ~ of variants as evidenced by the consistent ability of the typing sera to neutralize at least 1000 TCDs0 of 1514 virus. Two possible roles have been suggested (Narayan et al., 1977a, b, 1978) for visna virus variants in pathogenesis: as a mechanism for virus persistence, and as an explanation of lesion initiation. The present study, has, for the first time, provided data on the frequency of antigenic variants isolated over many years from one group of animals. Although the number of variants is substantial, there is no evidence that they replace the infecting serotype with the passage of time. Rather, parental and variant viruses appear to co-exist, suggesting that antigenic drift is not essential for virus persistence. Tests of 35 isolates with autologous sera confirmed this view. Since these 35 isolates were derived from cells constantly immersed in antibody-bearing fluids, this should have provided an optimal milieu for the selection of non-neutralizable variant viruses. Our findings resemble the observations of Narayan et al. (1978) who infected Hampshire and Border-Leicester sheep and found that, in two of seven animals studied, a number of buffy coat isolates were capable of totally escaping neutralization by autologous serum obtained at the time of, and for some interval after, virus isolation. It is clear that Icelandic sheep are more permissive for visna virus (P6tursson et al., 1976; P~lsson et al., 1977; Georgsson et al., 1978) than the sheep used by Narayan et al. (1974, 1977b). Infected Icelandic sheep may develop a broad serum-neutralizing response more rapidly (Henle & Lief, 1963) thereby limiting the replication of variant viruses (Narayan et al., 1981). The onset and course of clinical disease is notoriously variable and unpredictable in visna. This is confirmed in the present study in which 20 sheep have been followed for over 7 years with eight animals sacrificed with clinical disease at 3, 22, 30, 67, 78, 78, 86 and 90 months, respectively. Furthermore, our recent pathological observations (Georgsson et al., 1982) clearly indicate that individual sheep may simultaneously bear recent and old demyelinating lesions in various stages of evolution. Narayan et al. (1977a, 1978) and Clements et al. (1980) have suggested that this irregular course of CNS disease might be explained by the appearance in the CNS at unpredictable intervals of antigenic variants capable of temporarily escaping neutralization. We have now examined, by homotyping, 17 CNS and CSF isolates and, with autologous antiserum, 11 CNS isolates. The frequency of variant viruses (three of 17 isolates, or 18 ~) is similar to that seen with blood isolates (15~o). Although a majority of CNS isolates were made from sheep with clinical visna, all the variant isolates came from an animal without clinical visna. From these observations, we are forced to conclude that, although antigenic variants are preferentially selected in the CNS as in the blood, they do not appear to play an essential role in the evolution of CNS lesions. Similar findings and interpretations are being concurrently reported by Thormar et al. (1983). The expert technical assistance of Kolbrun Kistinsdottir, Noelle Naudot, and Sigurbjorg Thorsteinsdottir is gratefully acknowledged. This work was supported in part by USPHS grant NS REFERENCES CLEMENTS, J. E., PEDERSON, F. S., NARAYAN, O. & HASELTINE, W. S. (1980). Genomic changes associated with antigenic variation of visna virus during persistent infection. Proceedings of the National Academy of Sciences, U.S.A. 77, GEORGSSON, G., PI~TURSSON, G., PALSSON, P. A., MILLER, A. & NATHANSON, N. (1978). Experimental visna in fetal Icelandic sheep. Journal of Comparative Pathology 88, GEORGSSON, G., MARTIN, J. R., KLEIN, J., P,~LSSON, P. A., NATHANSON, N. & PI~TURSSCgN, G. (1982). Primary demyelination in visna. An ultrastructural study of Icelandic sheep with clinical signs following experimental infection. Acta neuropathologica 57,
8 1440 R. LUTLEY AND OTHERS GERHARD, ~., YEWDELL, J., FRANKEL, M. E., LOPES, A. D. & STAUDT, L. (1980). ionoclonal antibodies against influenza virus. In Monoclonal Antibodies, pp Edited by R. H. Kennett, T. S. McKearn & K. B. Bechtol. New York: Plenum Press. GUDNADOTTIR, M. (1974). Visna-maedi in sheep. Progress in Medical Virology 18, HAASE, A. T. (1975). The slow infection caused by visna virus. Current Topics in Microbiology and Immunology 72, HENLE, W. & LIEF, F. S. (1963). The broadening of antibody spectra following multiple exposures to influenza virus. American Review of Respiratory Diseases 88, LAVER, W. G., AIR, G. M., WEBSTER, R. G., GERHARD, W., WARD, C. W. & DOPHEIDE, T. A. A. (1979a). Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridomas. Virology 98, 22(~237. LAVER, W. G., GERHARD, W., WEBSTER, R. G., FRANKEL, M. E. & AIR, G. M. (1979 b). Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HONI) variants selected with monoclonal antibodies. Proceedings of the National Academy of" Sciences, U.S.A. 76, NARAYAN, O., SILVERSTEIN, A. M., PRICE, D. & JOHNSON, R. T. (1974). Visna virus infection of American lambs. Science 183, NARAYAN, O., GRIFFIN, D. E. & CHASE, S. (1977a). Antigenic shift of visna virus in persistently infected sheep. Science 197, NARAYAN, O., GRIFFIN, D. E. & SILVERSTEIN, A. M. (1977b). Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. Journal of InJectious Diseases 135, NARAYAN, O., GRIFFIN, D. E, & CLEMENTS, J. E. (1978). Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. JournalofGeneral Virology 41, NARAYAN, O., CLEMENTS, J. E., GRIFFIN, D. E. & WOLINSKY, J. S. (1981). Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infection and Immunity 32, NATHANSON, N., P!~TURSSON, G., GEORGSSON, G., P,~LSSON, P. A., MARTIN, J. R. & MILLER, A. (1979). Pathogenesis of visna. IV. Spinal fluid studies. Journal of Neuropathology and Experimental Neurology 38, Pi~LSSON, p. A., GEORGSSON, G., P~TURSSON, G. & NATHANSON, N. (1977). Experimental visna in Icelandic lambs. Acta veterinaria scandinavica 18, PETURSSON, G., NATHANSON, N., GEORGSSON, G., PANITCH, H. & P.~LSSON, P. A. (1976). Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Laboratory Investigation 35, 402~,12. PI~TURSSON, G., NATI-L~.NSON, N., P.~LSSON, P. A., MARTIN, J. R_ & GEORGSSON, G. (1978). Immunopathogenesis of visna, a slow virus disease of the nervous system. Acta neurologica scandinavica 57($67), P~TURSSON, G., MARTIN, J. R., GEORGSSON, G., NATHANSON, N. & P~,LSSON, P. A. (1979). Visna. The biology of the agent and the disease. In New Perspectives in Clinical Microbiology, pp Edited by D. A. J. Tyrrell. The Hague: Martinus Nijhoff. SCOTT, J. V., STOWRING, L., HAASE, A. T., NARAYAN, O. & VIGNE, R. (1979). Antigenic variation of visna virus. Cell 18, THORMAR, H., BARSHATZKY, M. R., ARNESEN, K. & KOZLOWSKI, P. B. (1983). The emergence of antigenic variants is a rare event in long-term visna virus infection in vivo. Journal of General Virology 64, WlKTOR, T. J. & KOPROWSKI, H. (1980). Antigenic variants of rabies virus. Journal of Experimental Medicine 152, (Received 18 January 1983)
Genomic Alterations Associated with Persistent Infections by Equine Infectious Anaemia Virus, a Retrovirus
J. gen. Virol. (1984), 65, 1395-1399. Printed in Great Britain 1395 Key words: EIA V/retrovirus persistence~antigenic variation/oligonucleotide mapping Genomic Alterations Associated with Persistent Infections
More informationEffect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity of Rotavirus SA-11
J. gen. Virol. (1985), 66, 2375-2381. Printed in Great Britain 2375 Key words: rotaviruses/antigenieity/antiserum selection Effect of Mutation in Immunodominant Neutralization Epitopes on the Antigenicity
More informationA Sequential Study of Virus Expression in Retrovirus-induced Arthritis of Goats
J. gen. Virol. (1984), 65, 1519-1525. Printed in Great Britain 1519 Key words: retrovirus/arthritis/viral persistence/pathogenesis A Sequential Study of Virus Expression in Retrovirus-induced Arthritis
More informationAntigenic Characterization of Measles and SSPE Virus Haemagglutinin by Monoclonal Antibodies
J. gen. Virol. (1981), 57, 357-364. Printed in Great Britain 357 Key words: measles/morbillivirus/monoclonal antibody Antigenic Characterization of Measles and SSPE Virus Haemagglutinin by Monoclonal Antibodies
More informationhemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide gel electrophoresis/genetics)
Proc. Natl. Acad. Sci. USA Vol. 73, No. 6, pp. 242-246, June 976 Microbiology Mapping of the influenza virus genome: Identification of the hemagglutinin and the neuraminidase genes (RNA/recombinant viruses/polyacrylamide
More informationNEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA
THE ENTEROVIRUS DEPARTMENT, STATENS SERUMINSTITUT, COPENHAGEN, DENMARK NEUTRALIZATION OF VISNA VIRUS BY HUMAN SERA By HALLD~R THORMAR~ and HERDIS VON MACNUS Received 28.ix.62 In a previous paper (12) the
More informationHemagglutinin Mutants of Swine Influenza Virus Differing in
INFECTION AND IMMUNITY, Oct. 1979, p. 197-201 0019-9567/79/10-0197/05$02.00/0 Vol. 26, No. 1 Hemagglutinin Mutants of Swine Influenza Virus Differing in Replication Characteristics in Their Natural Host
More informationThe antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells
Journal of General Virology (1990), 71, 1683 1688. Printed in Great Britain 1683 The antigenic structure of a human influenza A (H1N1) virus isolate grown exclusively in MDCK cells Phil J. Yates, Janet
More informationBiological Characterization of the Virus Causing Leukoencephalitis and Arthritis in Goats
J. gen. Virol. 098o), 5 o, 69-79 Printed in Great Britain 69 Biological Characterization of the Virus Causing Leukoencephalitis and Arthritis in Goats By OPENDRA NARAYAN, JANICE E. CLEMENTS, JOHN D. STRANDBERG,
More informationVaccination delays maedi-visna lentivirus infection in a naturally-infected sheep flock
Gudnadóttir et al. BMC Veterinary Research 2013, 9:16 RESEARCH ARTICLE Vaccination delays maedi-visna lentivirus infection in a naturally-infected sheep flock Margrét Gudnadóttir 1*, Andreas Demosthenous
More informationEvolution of influenza
Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal
More informationDirect isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition
Journal of General Virology (1991), 72, 185-189. Printed in Great Britain 185 Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition
More informationChronic Infections by Herpes Simplex Viruses and by the Horse and Cat Herpesviruses
INFECTION AND IMMUNITY, Apr. 70, p. 351-355 Copyright 70 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Chronic Infections by Herpes Simplex Viruses and by the Horse and Cat Herpesviruses
More informationAvian influenza Avian influenza ("bird flu") and the significance of its transmission to humans
15 January 2004 Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans The disease in birds: impact and control measures Avian influenza is an infectious disease
More informationProduction of Interferon Alpha by Dengue Virus-infected Human Monocytes
J. gen. Virol. (1988), 69, 445-449. Printed in Great Britain 445 Key words: IFN-ct/dengue virus/monocytes Production of Interferon Alpha by Dengue Virus-infected Human Monocytes By ICHIRO KURANE AND FRANCIS
More informationSerological studies on 40 cases of mumps virus
J Clin Pathol 1980; 33: 28-32 Serological studies on 40 cases of mumps virus infection R FREEMAN* AND MH HAMBLING From Leeds Regional Public Health Laboratory, Bridle Path, York Road, Leeds, UK SUMMARY
More informationph1n1 H3N2: A Novel Influenza Virus Reassortment
ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain
More informationAntigenic Analysis of Isolated Polypeptides from Visna Virus
INFECTION AND IMMUNITY, June 1976, p. 1728-1732 Copyright 1976 American Society for Microbiology Vol. 13, No. 6 Printed in USA. Antigenic Analysis of Isolated Polypeptides from Visna Virus P. D. MEHTA,*
More informationAntibodies Produced by Rabbits Immunized
INFECTION AND IMMUNITY, Dec. 1971, p. 715-719 Copyright 1971 American Society for Microbiology Vol. 4, No. 6 Printed in U.S.A. Antibodies Produced by Rabbits Immunized ith Visna Virus SEUNG C. KARL AND
More informationPathogenesis of Simian Foamy Virus Infection in Natural and Experimental Hosts
INCTION AD ImmuNrry, Sept. 1975, p. 470-474 Copyright 0 1975 American Society for Microbiology Vol. 12, No. 3 Printed in U.S.A. Pathogenesis of Simian Foamy Virus Infection in Natural and Experimental
More informationMin Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC
Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute
More informationEffect of Complement and Viral Filtration on the
APPLIED MICROBIOLOGY, JUlY 1968, p. 1076-1080 Copyright @ 1968 American Society for Microbiology Vol. 16, No. 7 Printed in U.S.A. Effect of Complement and Viral Filtration on the Neutralization of Respiratory
More informationPreparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP
Preparing for the Fall Flu Season Laboratory Perspective Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP September 21, 2009 Objectives 1. Review the emergence of Novel Influenza A
More informationIsolation of Influenza C Virus from Pigs and Experimental Infection of Pigs with Influenza C Virus
J. gen. Virol. (1983), 64, 177-182. Printed in Great Britain 177 Key words: influenza C virus/antibodies/pigs Isolation of Influenza C Virus from Pigs and Experimental Infection of Pigs with Influenza
More informationAntigenic Mapping of an Avian HI Influenza Virus Haemagglutinin and Interrelationships of HI Viruses from Humans, Pigs and Birds
J. gen. Virol. (1986), 67, 983-992. Printed in Great Britain 983 Key words: influenza A viruses ( H l ) / haemagglutinin/ monoclonal antibodies Antigenic Mapping of an Avian HI Influenza Virus Haemagglutinin
More informationV rology Springer-Vertag 1991 Printed in Austria
Arch Virot (1991) 119:37-42 _Archives V rology Springer-Vertag 1991 Printed in Austria Replication of avian influenza viruses in humans A. S. Beare 1'* and R. G. Webster: l Clinical Research Centre, Harvard
More informationPersistent Infection of MDCK Cells by Influenza C Virus: Initiation and Characterization
J. gen. Virol. (199), 70, 341-345. Printed in Great Britain 341 Key words: influenza C virus/interferon/persistent infection Persistent Infection of MDCK Cells by Influenza C Virus: Initiation and Characterization
More informationIntroduction.-Cytopathogenic viruses may lose their cell-destroying capacity
AN INHIBITOR OF VIRAL ACTIVITY APPEARING IN INFECTED CELL CULTURES* BY MONTO Hot AND JOHN F. ENDERS RESEARCH DIVISION OF INFECTIOUS DISEASES, THE CHILDREN'S MEDICAL CENTER, AND THE DEPARTMENT OF BACTERIOLOGY
More informationANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS
ANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS F. 0. MACCALLUM, I. J. CHINN AND J. V. T. GOSTLMG Virology Laboratory, Radclife Infirmary, Oxford
More informationCurrent Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?
Current Vaccines: Progress & Challenges Influenza Vaccine what are the challenges? Professor John S. Tam The Hong Kong Polytechnic University Asia-Pacific Alliance for the Control of Influenza (APACI)
More informationRadioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection
J. gen. Virol. (I977), 3 6, ~ 371-375 Printed in Great Britain 371 Radioimmunoassay of Herpes Simplex Virus Antibody: Correlation with Ganglionic Infection By B. FORGHANI, TONI KLASSEN AND J. R. BARINGER
More informationVIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks
INFLUENZA VIROLOGY OF INFLUENZA Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks PATHOGENICITY High pathogenicity avian influenza (HPAI) Causes severe disease in poultry
More informationWHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update
WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update 23 July 2009 Introduction This document updates guidance 1 from the World
More informationTHE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP.
Onderstepoort Journal of Veterinary Research, Volume 27, Number 2, October, 1956. The Government Printer. THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION
More informationDetection of neuraminidase-inhibiting antibodies for measurement of Influenza vaccine immunogenicity
Borgis New Med 2015; 19(4): 147-155 DOI: 10.5604/14270994.1191796 Detection of neuraminidase-inhibiting antibodies for measurement of Influenza vaccine immunogenicity *Mónika Rózsa 1, István Jankovics
More informationVisna Virus dutpase Is Dispensable for Neuropathogenicity
JOURNAL OF VIROLOGY, Feb. 1998, p. 1657 1661 Vol. 72, No. 2 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Visna Virus dutpase Is Dispensable for Neuropathogenicity GUDMUNDUR PÉTURSSON,
More information(;[rowth Charaeteristies of Influenza Virus Type C in Avian Hosts
Archives of Virology 58, 349--353 (1978) Archives of Virology by Springer-Verlag 1978 (;[rowth Charaeteristies of Influena Virus Type C in Avian Hosts Brief Report By M ~R A~N D. AUSTIn, A. S. MONTO, and
More informationAntigenic Variation between Human Respiratory Syncytial Virus Isolates
J. gen. Virol. (1986), 67, 863-870. Printed in Great Britain 863 Key words: RS virus/antigenic variation/phosphoprotein Antigenic Variation between Human Respiratory Syncytial Virus Isolates By H. B. GIMENEZ,*
More informationWhat is influenza virus? 13,000 base RNA genome: 1/ the size of the human genome
What is influenza virus? 13,000 base RNA genome: 1/246153 the size of the human genome CDC Principles of Virology, 4e Neumann et al. Nature. 2009. Influenza virus is one of the most deadly viral pathogens
More informationHemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationVariation in the HindlII Restriction Fragments of DNA from the Chinese Tian Tan Strain of Vaccinia Virus
J. gen. irol. (1985), 66, 1819-1823. Printed in Great Britain 1819 Key words: vaccinia virus~vaccine~restriction Jragrnent variation ariation in the Hindl Restriction Fragments of DNA from the Chinese
More informationThis product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for
This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference and Research on Influenza, with material provided
More informationCoronaviruses cause acute, mild upper respiratory infection (common cold).
Coronaviruses David A. J. Tyrrell Steven H. Myint GENERAL CONCEPTS Clinical Presentation Coronaviruses cause acute, mild upper respiratory infection (common cold). Structure Spherical or pleomorphic enveloped
More informationTITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
More informationNEUTRALIZATION OF REOVIRUS: THE GENE RESPONSIBLE FOR THE NEUTRALIZATION ANTIGEN* BY HOWARD L. WEINER~ AN~ BERNARD N. FIELDS
NEUTRALIZATION OF REOVIRUS: THE GENE RESPONSIBLE FOR THE NEUTRALIZATION ANTIGEN* BY HOWARD L. WEINER~ AN~ BERNARD N. FIELDS (From the Department of Microbiology and Molecular Genetics, Harvard Medical
More informationLecture 19 Evolution and human health
Lecture 19 Evolution and human health The evolution of flu viruses The evolution of flu viruses Google Flu Trends data US data Check out: http://www.google.org/flutrends/ The evolution of flu viruses the
More informationAntigenic Variation of Envelope and Internal Proteins of Mumps Virus Strains Detected with Monoclonal Antibodies
J. gen. Virol. (1986), 67, 281 287. Printed in Great Britain 281 Key words : mumps virus/antigenic subtypes/monoclonal antibodies Antigenic Variation of Envelope and Internal Proteins of Mumps Virus Strains
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More informationREVIEW ARTICLE. Slow Virus Infections of the Nervous System: Virological, Immunological and Pathogenetic Considerations
J. gem Virol. 0978), 4I, 1-25 Printed in Great Brim& REVIEW ARTICLE Slow Virus Infections of the Nervous System: Virological, Immunological and Pathogenetic Considerations By V. TER MEULEN AND W. W. HALL*
More informationBrief Definitive Report
Brief Definitive Report HEMAGGLUTININ-SPECIFIC CYTOTOXIC T-CELL RESPONSE DURING INFLUENZA INFECTION BY FRANCIS A. ENNIS, W. JOHN MARTIN, ANY MARTHA W. VERBONITZ (From the Department of Health, Education
More informationSTUDIES UPON THE POSSIBILITIES OF AVIAN INFLUENZA VIRUSES CULTIVATION IN CHICK EMBRYOS AT DIFFERENT AGE
Bulgarian Journal of Veterinary Medicine (2006), 9, No 1, 4349 STUDIES UPON THE POSSIBILITIES OF AVIAN INFLUENZA VIRUSES CULTIVATION IN CHICK EMBRYOS AT DIFFERENT AGE I. S. ZARKOV Faculty of Veterinary
More informationDistinctive Characteristics of Crude Interferon from Virus-infected Guinea-pig Embryo Fibroblasts
J. gen. Virol. (1984), 65, 843-847. Printed in Great Britain 843 Key words: IFN/guinea-pig/acid-labile Distinctive Characteristics of Crude Interferon from Virus-infected Guinea-pig Embryo Fibroblasts
More informationMapping the Antigenic and Genetic Evolution of Influenza Virus
Mapping the Antigenic and Genetic Evolution of Influenza Virus Derek J. Smith, Alan S. Lapedes, Jan C. de Jong, Theo M. Bestebroer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Ron A. M. Fouchier Science
More informationThe Isolation of Large and Small Plaque Canine Distemper Viruses which Differ in their Neurovirulence for Hamsters SUMMARY
J. gen. Virol. (1981), 52, 345-353 Printed in Great Britain 345 The Isolation of Large and Small Plaque Canine Distemper Viruses which Differ in their Neurovirulence for Hamsters By S. L. COSBY, 1. C.
More informationGene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
More informationCristina Cassetti, Ph.D.
NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID
More informationReassortment of influenza A virus genes linked to PB1 polymerase gene
International Congress Series 1263 (2004) 714 718 Reassortment of influenza A virus genes linked to PB1 polymerase gene Jean C. Downie* www.ics-elsevier.com Centre for Infectious Diseases and Microbiology,
More informationVirus Genetic Diversity
Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline
More informationHS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.
Unit 2, Lesson 2: Teacher s Edition 1 Unit 2: Lesson 2 Influenza and HIV Lesson Questions: o What steps are involved in viral infection and replication? o Why are some kinds of influenza virus more deadly
More informationViral vaccines. Lec. 3 أ.د.فائزة عبد هللا مخلص
Lec. 3 أ.د.فائزة عبد هللا مخلص Viral vaccines 0bjectives 1-Define active immunity. 2-Describe the methods used for the preparation of attenuated live & killed virus vaccines. 3- Comparison of Characteristics
More informationSURVEILLANCE TECHNICAL
CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect
More informationThe Assay of Influenza Antineuraminidase Activity by an Elution Inhibition Technique
3.. gen. Virol. (1977), 34, 137-I44 Printed in Great Britain 137 The Assay of Influenza Antineuraminidase Activity by an Elution Inhibition Technique By G. APPLEYARD AND J. D. ORAM Microbiological Research
More informationBBS2711 Virology. Central Nervous System (CNS) Viruses. Dr Paul Young, Department of Microbiology & Parasitology.
BBS2711 Virology Central Nervous System (CNS) Viruses Dr Paul Young, Department of Microbiology & Parasitology. p.young@mailbox.uq.edu.au Viruses of the CNS Many human pathogenic viruses are capable of
More informationhowever, and the present communication is concerned with some of
THE AGGLUTINATION OF HUMAN ERYTHROCYTES MODIFIED BY TREATMENT WITH NEWCASTLE DISEASE AND INFLUENZA VIRUS' ALFRED L. FLORMAN' Pediatric Service and Division of Bacteriology, The Mount Sinai Hospital, New
More informationIsolation of Different Serotypes in Human Heteroploid
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1977, p. 202-207 Copyright 1977 American Society for Microbiology Vol. 5, No. 2 Printed in U.S.A. Demonstration of Dual Rhinovirus Infection in Humans by Isolation
More informationREAGENTS FOR THE TYPING OF HUMAN INFLUENZA ISOLATES 2017
REAGENTS FOR THE TYPING OF HUMAN INFLUENZA ISOLATES 2017 This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference
More informationStudying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID
Studying Repeated Immunization in an Animal Model Kanta Subbarao Laboratory of Infectious Diseases, NIAID Animal models in Influenza Research Commonly used Mice Ferrets Guinea pigs Non human primates Less
More informationHuman Neurology 3-Plex A
Human Neurology 3-Plex A SUMMARY AND EXPLANATION OF THE TEST The Human N3PA assay is a digital immunoassay for the quantitative determination of total Tau, Aβ42, and Aβ40 in human plasma and CSF. Determination
More informationDengue Infection at Children's Hospital of Bangkok
Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,
More informationReagents for the Typing of Human Influenza Isolates 2011
Reagents for the Typing of Human Influenza Isolates 2011 This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for Reference
More informationThe pathogenesis of nervous distemper
Veterinary Sciences Tomorrow - 2004 The pathogenesis of nervous distemper Marc Vandevelde Canine distemper is a highly contagious viral disease of dogs and of all animals in the Canidae, Mustellidae and
More informationNeutralization Epitopes on Poliovirus Type 3 Particles: an Analysis Using Monoclonal Antibodies
J.-gen. Virol. (1984), 65, 197-201. Printed in Great Britain 197 Key words: poliovirus type 3/monoclonal Abs/neutralization/immunoblot Neutralization Epitopes on Poliovirus Type 3 Particles: an Analysis
More informationIsolation of Rhinovirus Intertypes Related to Either Rhinoviruses 12 and 78 or 36 and 58
INFECTION AND IMMUNITY, Apr. 1983, p. 213-218 0019-9567/83/040213-06$02.00/0 Copyright 1983, American Society for Microbiology Isolation of Rhinovirus Intertypes Related to Either Rhinoviruses 12 and 78
More information(From the Department of Epidemiology and Virus Laboratory, School of Pubbic Health, University of Michigan, Ann Arbor) Methods
Published Online: 1 November, 1948 Supp Info: http://doi.org/1.184/jem.88.5.515 Downloaded from jem.rupress.org on May 3, 218 THE RELATION OF INFECTIOUS AND HEMAGGLUTINATION TITERS TO THE ADAPTATION OF
More informationStructure of viruses
Antiviral Drugs o Viruses are obligate intracellular parasites. o lack both a cell wall and a cell membrane. o They do not carry out metabolic processes. o Viruses use much of the host s metabolic machinery.
More informationUpdate on influenza monitoring and vaccine development
Update on influenza monitoring and vaccine development Annette Fox WHO Collaborating Centre for Reference and Research on Influenza at The Peter Doherty Institute for Infection and Immunity 1 Outline Why
More informationUpdate of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines
Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines 28 May 2009 Introduction This document updates WHO guidance 1 to national
More informationFluSure XP TM Update with Regards to 2009 H1N1 Swine Influenza Virus
FluSure XP TM Update with Regards to 2009 H1N1 Swine Influenza Virus Although the 2009 H1N1 swine influenza virus has not been identified in US swine herds, it should be noted that swine influenza vaccines,
More informationChallenges in Vaccine Production and Rapid Scale up to Meet Emerging Pandemic Threats
Challenges in Vaccine Production and Rapid Scale up to Meet Emerging Pandemic Threats Susan Dana Jones, Ph.D. BioProcess Technology Consultants, Inc. BIO 2009 Process Zone Theater Atlanta, GE May 20, 2009
More informationINFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE
INFLUENZA VIRUS INFLUENZA VIRUS CDC WEBSITE http://www.cdc.gov/ncidod/diseases/flu/fluinfo.htm 1 THE IMPACT OF INFLUENZA Deaths: PANDEMICS 1918-19 S p a n is h flu 5 0 0,0 0 0 U S 2 0,0 0 0,0 0 0 w o rld
More informationSubtype Cross-Reactive, Infection-Enhancing Antibody
JOURNAL OF VIROLOGY, June 1994, p. 3499-3504 0022-538X/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 68, No. 6 Subtype Cross-Reactive, Infection-Enhancing Antibody Responses to Influenza
More informationLipopolysaccharide, and Outer Membrane in Adults Infected with
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 984, p. 54-58 0095-37/84/54-05$0.00/0 Copyright 3 984, American Society for Microbiology Vol. 0, No. 6 Antibody Responses to Capsular Polysaccharide, Lipopolysaccharide,
More informationAntigenic Conservation of H1N1 Swine Influenza Viruses
J. gen. Virol. (1989), 70, 3297-3303. Printed in Great Britain 3297 Key words: influenza/haernagglutinin/swine Antigenic Conservation of H1N1 Swine Influenza Viruses By M. G. SHEERAR, B. C. EASTERDAY AND
More informationBY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY
J. gen. Microbial. (1963), 31, 179186 Prinied in Great Britain 179 The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of FootandMouth Disease Virus and on its Attachment
More informationOverview and Future Plans: Laboratory Working Group. John Wood and Othmar Engelhardt CONSISE Open Meeting, Cape Town South Africa 4 September 2013
Overview and Future Plans: Laboratory Working Group John Wood and Othmar Engelhardt CONSISE Open Meeting, Cape Town South Africa 4 September 2013 Background: 1st International Influenza Seroprevalence
More informationAcute neurological syndromes
Acute neurological syndromes Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical
More informationTHE SIMULTANEOUS OCCURRENCE OF THE VIRUSES OF CANINE DISTEMPER AND LYMPHOCYTIC CHORIOMENINGITIS*
Published Online: 1 July, 1939 Supp Info: http://doi.org/10.1084/jem.70.1.19 Downloaded from jem.rupress.org on October 22, 2018 THE SIMULTANEOUS OCCURRENCE OF THE VIRUSES OF CANINE DISTEMPER AND LYMPHOCYTIC
More informationSUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS
SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS RONALD G. MARSHALL AND PETER J. GERONE U. S. Army Chemical Corps, Fort Detrick, Frederick, Maryland Received for publication December, 6 ABSTRACT MARSHALL,
More informationLikelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza
JCM Accepts, published online ahead of print on 3 June 2009 J. Clin. Microbiol. doi:10.1128/jcm.01027-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationUnit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS
1 Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS What steps are involved in viral infection and replication? Why are some kinds of influenza virus more deadly than others? How do flu
More informationLESSON 4.5 WORKBOOK. How do viruses adapt Antigenic shift and drift and the flu pandemic
DEFINITIONS OF TERMS Gene a particular sequence of DNA or RNA that contains information for the synthesis of a protien or RNA molecule. For a complete list of defined terms, see the Glossary. LESSON 4.5
More informationDownloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk
1 Virus-Receptor Interactions BERNARD N. FIELDS Department of Microbiology and Molecular Genetics, Harvard Medical School, and Department of Medicine (Infectious Disease), Brigham and Women's Hospital,
More informationCompartmentalized HIV and SIV Populations in the Central Nervous System Are Associated with Neuropathogenesis
Compartmentalized HIV and SIV Populations in the Central Nervous System Are Associated with Neuropathogenesis Gretja Schnell Graduate Student Laboratory of Ronald Swanstrom Department of Microbiology and
More informationIncorporating virologic data into seasonal and pandemic influenza vaccines
Incorporating virologic data into seasonal and pandemic influenza vaccines Kanta Subbarao WHO Collaborating Centre for Reference and Research on Influenza & Department of Microbiology and Immunology, University
More informationNEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar
NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock
More informationCurrent Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study
Note: I have added some clarifying comments to the slides -- please click on Comments under View to see them. Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a
More information(From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey)
THE YIELD OF RABIES VIRUS IN THE CHICK EMBRYO BY BJORN SIGURDSSON, M.D.* (From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey) (Received
More informationGrade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period
The History of Vaccines Lesson Plan: Viruses and Evolution Overview and Purpose: The purpose of this lesson is to prepare students for exploring the biological basis of vaccines. Students will explore
More informationINFLUENZA-2 Avian Influenza
INFLUENZA-2 Avian Influenza VL 7 Dec. 9 th 2013 Mohammed El-Khateeb Overview 1. Background Information 2. Origin/History 3. Brief overview of genome structure 4. Geographical Distribution 5. Pandemic Nature
More informationWORLD HEALTH ORGANIZATION. Smallpox eradication: destruction of Variola virus stocks
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB111/5 111th Session 23 December 2002 Provisional agenda item 5.3 Smallpox eradication: destruction of Variola virus stocks Report by the Secretariat 1. The WHO
More information